New hope for advanced cervical cancer: major trial tests powerful drug combo
NCT ID NCT07400536
Summary
This study is testing whether adding a new immunotherapy drug called cadonilimab to standard chemotherapy and radiation works better than standard treatment alone for locally advanced cervical cancer. It will involve 378 women with stage IIB-IVA cervical cancer who haven't had previous cancer treatment. Researchers will compare how long patients live without their cancer getting worse between the two treatment approaches.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED CERVICAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.